These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
528 related articles for article (PubMed ID: 17194908)
21. Long-term outcome of salvage high-dose chemotherapy in patients with germ cell tumor with poor prognostic features. De Giorgi U; Rosti G; Salvioni R; Papiani G; Ballardini M; Pizzocaro G; Marangolo M Urol Oncol; 2011; 29(3):284-90. PubMed ID: 19556152 [TBL] [Abstract][Full Text] [Related]
22. High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer. Bessho A; Ueoka H; Kiura K; Tabata M; Sunami K; Katayama Y; Yamane H; Hiraki A; Harada M Anticancer Res; 1999; 19(1B):693-8. PubMed ID: 10216478 [TBL] [Abstract][Full Text] [Related]
23. Tandem high-dose chemotherapy with ifosfamide, carboplatin, and teniposide with autologous bone marrow transplantation for the treatment of poor prognosis common epithelial ovarian carcinoma. Lotz JP; Bouleuc C; André T; Touboul E; Macovei C; Hannoun L; Lefranc JP; Houry S; Uzan S; Izrael V Cancer; 1996 Jun; 77(12):2550-9. PubMed ID: 8640705 [TBL] [Abstract][Full Text] [Related]
24. [High-dose chemotherapy with peripheral blood stem cell autotransplantation for patients with poor-risk testicular germ cell tumors--pilot study of the Japan Blood Cell Transplantation Study Group]. Nakagawa S; Miki T; Akaza H; Ozono S; Okano T; Sonoda Y; Tsukamoto T; Terachi T; Naito K; Naito S; Nishiyama T; Nonomura N; Hara I; Hoshi S; Yoshida O Hinyokika Kiyo; 1999 Nov; 45(11):805-9. PubMed ID: 10637748 [TBL] [Abstract][Full Text] [Related]
26. Phase I/II Trial of Paclitaxel With Ifosfamide Followed by High-Dose Paclitaxel, Ifosfamide, and Carboplatin (TI-TIC) With Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell Tumors. Feldman DR; Glezerman I; Patil S; Van Alstine L; Bajorin DF; Fischer P; Hughes A; Sheinfeld J; Bains M; Reich L; Woo K; Giralt S; Bosl GJ; Motzer RJ Clin Genitourin Cancer; 2015 Oct; 13(5):453-60. PubMed ID: 26072101 [TBL] [Abstract][Full Text] [Related]
27. Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer. Wandt H; Birkmann J; Denzel T; Schäfer K; Schwab G; Pilz D; Egger H; Both A; Gallmeier WM Bone Marrow Transplant; 1999 Apr; 23(8):763-70. PubMed ID: 10231137 [TBL] [Abstract][Full Text] [Related]
28. High dose chemotherapy and stem cell support in the treatment of germ cell cancer. Margolin K J Urol; 2003 Apr; 169(4):1229-33. PubMed ID: 12629333 [TBL] [Abstract][Full Text] [Related]
29. High dose chemotherapy as salvage treatment for unresectable late relapse germ cell tumors. Lorch A; Rick O; Wündisch T; Hartmann JT; Bokemeyer C; Beyer J J Urol; 2010 Jul; 184(1):168-73. PubMed ID: 20483152 [TBL] [Abstract][Full Text] [Related]
30. Treatment results in children and adolescents with loco-regional recurrences of abdominal germ cell tumors (GCTs): a pilot-study with PEI chemotherapy and regional deep hyperthermia (RHT) in comparison to a matched cohort. Wessalowski R; Blohm M; Calaminus G; Engert J; Harms D; Krause I; Kruck H; Grüttner HP; Pape H; Göbel U Klin Padiatr; 1997; 209(4):250-6. PubMed ID: 9293458 [TBL] [Abstract][Full Text] [Related]
32. High-dose chemotherapy with haematopoietic stem-cell support in patients with poor prognosis, relapsed or refractory germ cell tumours. El-Helw LM; Naik JD; Chester JD; Joffe JK; Selby PJ; Coleman RE BJU Int; 2006 Sep; 98(3):519-25. PubMed ID: 16925746 [TBL] [Abstract][Full Text] [Related]
33. A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial. Leyvraz S; Pampallona S; Martinelli G; Ploner F; Perey L; Aversa S; Peters S; Brunsvig P; Montes A; Lange A; Yilmaz U; Rosti G; J Natl Cancer Inst; 2008 Apr; 100(8):533-41. PubMed ID: 18398095 [TBL] [Abstract][Full Text] [Related]
34. Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma. Abali H; Urün Y; Oksüzoğlu B; Budakoğlu B; Yildirim N; Güler T; Ozet G; Zengin N Cancer Invest; 2008 May; 26(4):401-6. PubMed ID: 18443961 [TBL] [Abstract][Full Text] [Related]
35. Salvage chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in relapsed or cisplatin-refractory germ cell tumors. Park S; Lee S; Lee J; Park SH; Park JO; Kang WK; Park YS; Lim HY Onkologie; 2011; 34(8-9):416-20. PubMed ID: 21934340 [TBL] [Abstract][Full Text] [Related]
36. Intensive chemotherapy with autologous peripheral blood stem cell transplantation during a 10-year period in 64 patients with germ cell tumor. Müller AM; Ihorst G; Waller CF; Dölken G; Finke J; Engelhardt M Biol Blood Marrow Transplant; 2006 Mar; 12(3):355-65. PubMed ID: 16503505 [TBL] [Abstract][Full Text] [Related]
37. Stable hematopoietic recovery after peripheral blood stem cell transplantation in patients receiving high-dose chemotherapy for advanced germ cell tumors. Kumano M; Miyake H; Hara I; Furukawa J; Takenaka A; Fujisawa M Anticancer Res; 2006; 26(6C):4965-8. PubMed ID: 17214371 [TBL] [Abstract][Full Text] [Related]
38. Paclitaxel, ifosfamide, and nedaplatin (TIN) salvage chemotherapy for patients with advanced germ cell tumors. Nonomura N; Oka D; Nishimura K; Nakayama M; Inoue H; Mizutani Y; Miki T; Okuyama A Int J Urol; 2007 Jun; 14(6):527-31. PubMed ID: 17593098 [TBL] [Abstract][Full Text] [Related]
39. Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network Study. Hainsworth JD; Spigel DR; Litchy S; Greco FA J Clin Oncol; 2006 Aug; 24(22):3548-54. PubMed ID: 16877720 [TBL] [Abstract][Full Text] [Related]
40. Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide for patients with relapsed primary mediastinal nonseminomatous germ cell tumors: benefit from chemotherapy, surgery, or both? Einhorn LH; Abonour R; Kesler KA J Clin Oncol; 2010 Dec; 28(35):e739; author reply e740. PubMed ID: 21060034 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]